Business Description
Walgreens Boots Alliance Inc
NAICS : 446110
SIC : 5912
ISIN : US9314271084
Share Class Description:
WBO:WBA: Ordinary SharesCompare
Compare
Traded in other countries / regions
WBA.USA0LSZ.UKWBA.MexicoW8A.GermanyWGBA34.Brazil1WBA.ItalyWBA.Austria IPO Date
2017-05-22Description
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the US, with over 8,000 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the US. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.1 | |||||
| Equity-to-Asset | 0.13 | |||||
| Debt-to-Equity | 3.15 | |||||
| Debt-to-EBITDA | -2.91 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 1.61 | |||||
| Beneish M-Score | -2.34 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3.8 | |||||
| 3-Year EPS without NRI Growth Rate | -16.3 | |||||
| 3-Year Book Growth Rate | -23.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | -16.14 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 1.58 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.44 | |||||
| 9-Day RSI | 44.51 | |||||
| 14-Day RSI | 47.67 | |||||
| 6-1 Month Momentum % | -50.57 | |||||
| 12-1 Month Momentum % | -58.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.68 | |||||
| Quick Ratio | 0.37 | |||||
| Cash Ratio | 0.12 | |||||
| Days Inventory | 26.01 | |||||
| Days Sales Outstanding | 14.51 | |||||
| Days Payable | 39.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 13.25 | |||||
| Dividend Payout Ratio | 0.43 | |||||
| 3-Year Dividend Growth Rate | -13.2 | |||||
| Forward Dividend Yield % | 10.84 | |||||
| 5-Year Yield-on-Cost % | 10.42 | |||||
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | 46.04 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 17.96 | |||||
| Operating Margin % | -1.08 | |||||
| Net Margin % | -5.85 | |||||
| FCF Margin % | -0.26 | |||||
| ROE % | -56.02 | |||||
| ROA % | -9.75 | |||||
| ROIC % | -2.28 | |||||
| 3-Year ROIIC % | 165.32 | |||||
| ROC (Joel Greenblatt) % | -43.29 | |||||
| ROCE % | -21.8 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 5.93 | |||||
| PE Ratio without NRI | 3.21 | |||||
| Shiller PE Ratio | 4.06 | |||||
| PS Ratio | 0.05 | |||||
| PB Ratio | 0.76 | |||||
| Price-to-Operating-Cash-Flow | 7.86 | |||||
| EV-to-EBIT | -2.75 | |||||
| EV-to-Forward-EBIT | 114.84 | |||||
| EV-to-EBITDA | -3.35 | |||||
| EV-to-Forward-EBITDA | 17.47 | |||||
| EV-to-Revenue | 0.26 | |||||
| EV-to-Forward-Revenue | 0.25 | |||||
| EV-to-FCF | -103.95 | |||||
| Price-to-Projected-FCF | 0.24 | |||||
| Price-to-Median-PS-Value | 0.14 | |||||
| Earnings Yield (Greenblatt) % | -36.36 | |||||
| FCF Yield % | -4.54 | |||||
| Forward Rate of Return (Yacktman) % | 46.47 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Walgreens Boots Alliance Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 135,944.276 | ||
| EPS (TTM) (€) | -9.21 | ||
| Beta | 0.81 | ||
| Volatility % | 49.63 | ||
| 14-Day RSI | 47.67 | ||
| 14-Day ATR (€) | 0.297876 | ||
| 20-Day SMA (€) | 8.72855 | ||
| 12-1 Month Momentum % | -58.63 | ||
| 52-Week Range (€) | 7.42 - 24.22 | ||
| Shares Outstanding (Mil) | 864.62 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Walgreens Boots Alliance Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Walgreens Boots Alliance Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Walgreens Boots Alliance Inc Frequently Asked Questions
What is Walgreens Boots Alliance Inc(WBO:WBA)'s stock price today?
The current price of WBO:WBA is €8.56. The 52 week high of WBO:WBA is €24.22 and 52 week low is €7.42.
When is next earnings date of Walgreens Boots Alliance Inc(WBO:WBA)?
The next earnings date of Walgreens Boots Alliance Inc(WBO:WBA) is 2025-01-03 Est..
Does Walgreens Boots Alliance Inc(WBO:WBA) pay dividends? If so, how much?
The Dividend Yield %  of Walgreens Boots Alliance Inc(WBO:WBA) is 13.25% (As of Today), Highest Dividend Payout Ratio of Walgreens Boots Alliance Inc(WBO:WBA) was 0.48. The lowest was 0.27. And the median was 0.37. The  Forward Dividend Yield % of Walgreens Boots Alliance Inc(WBO:WBA) is 10.84%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers